H.I.G. BioVentures
H.I.G. BioVentures invests in companies developing innovative
products for significant unmet medical needs in therapeutics,
medical device technology, specialty pharmaceuticals and
diagnostics. A natural extension of the broader H.I.G. Capital
platform, H.I.G. BioVentures invests across a broad range of stages
and leverages its team of seasoned senior investment professionals
who have over 75 combined years of experience in life sciences
investing, operations, business development, sales and marketing,
research management, financ, and technology development. Our
ability to leverage the broader H.I.G. infrastructure and resources
provides significant value to our portfolio companies and partners.
H.I.G. BioVentures is the life sciences venture capital affiliate
of H.I.G. Capital, a leading global private investment firm with
over $7.5 billion of capital under management and U.S. offices in
Atlanta, Boston, Miami, New York and San Francisco.